Molecular-Docking Study of Quinazolin-4(3H)-One Derivatives Against GABAa Receptor Signifies the Novel Approach to Epilepsy Treatment. Int. J. Pharm. Sci. Drug Res. 2020, 12 (5), 572-575. https://doi.org/10.25004/IJPSDR.2020.120521.